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common in horses used for fast galloping disciplines such as racing. It
has been previously documented that cracks in the calciﬁed cartilage
and underlying subchondral bone are common in animals such as the
Thoroughbred racehorse (TBs). A repair mechanism occurs in these animals
in which microcracks are healed and sealed by the intrusion of very dense
mineralised matrix. In this study we aimed to determine the relationship
between the presence of such cracks (and their subsequent repair) with
hyaline articular cartilage (HAC) pathology.
Methods: In the present study we examined the 75 palmar/plantar
condyles of metacarpus/metatarsus III of 43 race trained TBs euthanased
for welfare reasons. Five 2mm thick parasagittal slices were cut from
the palmar/plantar quadrant of the condyle. The most abaxial slice was
macerated and the morphology of the mineralised tissue at the joint
surface was examined by 3D back-scattered electron SEM (BSE SEM). The
adjacent B slice was embedded in PMMA, and the resulting block surface
polished and studied using combined autoﬂuorescence confocal scanning
light microscopy (AFCSLM) and quantitative BSE SEM. Histology of the
block surface layer could be obtained by AFCSLM before or after the SEM
study. A more axial slice was ﬁxed in 10% formaldehyde, stored in 70%
ethanol prior to decalciﬁcation and paraﬃn embedding. Sections (8μM)
were cut and stained with H&E, Safranin-O, Alcian Blue and Massons
Trichrome stains.
Results: In a number of cases dense projections were observed extending
from cracks at the plane of the articular calciﬁed cartilage (ACC) mineralis-
ing front into the HAC. These correlated with highly mineralised projections
into the HAC seen by BSE SEM of block face preparations. These projections
matched the density of the crack inﬁll material seen in the same study, and
in samples from previous studies, and are surrounded by normal healthy
looking HAC with the cartilage being cleaved to provide the space.
These mineralised projections could extend up to half to two-thirds through
the thickness of the HAC, and in all cases were associated with focal HAC
ﬁbrillation directly overlying their site. These mineralised projections were
visualised using AFCSLM and SEM, but were not identiﬁed on any section
using conventional paraﬃn embedded decalciﬁed sections.
Conclusions: In certain circumstances the mechanism by which cracks
in the subchondral bone and articular calicifed cartilage may be repaired
result in extension of calciﬁed matrix beyond the mineralised tissue and
into the overlying HAC. The presence of such mineralised projections in all
instances resulted in obvious HAC ﬁbrillation and superﬁcial cartilage loss
directly overlying their site. We hypothesised that this hard, dense material
might fragment, migrate within the HAC and eventually enter the joint
space as abrasive fragments, probably explaining wear lines, which are an
extremely common pathology in this joint in this particular population of
horses. In keeping with this, in some instances we found isolated fragments
within the HAC remote from the tidemark mineralising front. Given their
high mineral content, they appeared to be completely removed by tissue
demineralisation were not identiﬁed in decalciﬁed paraﬃn embedded sec-
tions obtained from the same joint. The combination of methods used here
has therefore permitted their discovery. This is the ﬁrst description of such
HAC pathology and appears to be a novel mechanism for osteoarthritis in
this group of animals.
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INVOLVEMENT OF RAS AND REACTIVE OXYGEN SPECIES IN
PROINFLAMMATORY CYTOKINE-INDUCED MMP-13 EXPRESSION IN
HUMAN ARTICULAR CHONDROCYTES
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Univ. of Montreal, Montreal, QC, Canada
Purpose: Proinﬂammatory cytokines such as interleukin-1 beta (IL-1β)
and tumor necrosis factor alpha (TNF-α) enhance cartilage-speciﬁc type
II collagen degradation by matrix metalloproteinase-13 (MMP-13). We
investigated the poorly studied role of H-Ras and reactive oxygen species
(ROS) in the induction of MMP-13 gene expression in chondrocytes.
Methods: Normal human knee chondrocytes were grown in Differentia-
tion Bullekit medium as high-density short-term monolayer cultures. Cells
were either treated with various pharmacological inhibitors, antioxidants
or transfected with negative control or Ras-speciﬁc siRNAs. Subsequently,
cells were stimulated with IL-1β or TNF-α for 24 h. Effect of respective
proteins knockdown on MMP-13 expression or activity was studied by
RT-PCR, MMP-13 ELISA and Western blot analysis.
Results: Treatment of chondrocytes with Manumycin, a speciﬁc inhibitor of
Ras, suppressed IL-1β- and TNF-α-induced MMP-13 enzyme activity using
a MMP-13-specﬁc ELISA. siRNA-mediated Ras silencing down-regulated
MMP-13 mRNA and protein induction by IL-1β and TNF-α. NADPH oxidase
inhibitor, Diphenyleneiodonium (DPI) suppressed IL-1β- and TNF-α-induced
MMP-13 enzyme activity. Role of ROS production was further reinforced
by the observation that the antioxidants, Trolox and Nordihydroguaiaretic
acid downregulated Interleukin-1β-and TNF-α-induced MMP-13 mRNA and
protein expression. Similarly, Quercetin and Resveratrol inhibited MMP-13
activity.
Conclusions: These results provide strong pharmacological and genetic
evidence for the importance of Ras and NADPH oxidase-generated reactive
oxygen species production in MMP-13 gene regulation and enzyme activity
by IL-1 and TNF-α.
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EFFECTS OF PPAR-γ AGONIST ON ADVANCED GLYCATION END
PRODUCTS-STIMULATED COX-2, PGE2, AND NO PRODUCTIONS IN HUMAN
OSTEOARTHRITIC CHONDROCYTES
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Purpose: Recently, we reported that advanced glycation end products
(AGEs) increase expressions of cyclooxygenase-2 (COX-2), prostaglandin E2
(PGE2), and nitiric oxide (NO) productions in human osteoarthritic (OA)
chondrocytes. In this study, we investigated the effects of peroxisome
proliferator activated receptor-γ (PPAR-γ) agonists (ciglitazone, CGZ; rosili-
tazone, RGZ; PGJ2, prostaglandin J2) on AGEs-stimulated COX-2, PGE2, and
NO productions in human OA chondrocytes.
Methods: OA chondrocytes were cultured with/or without advanced gly-
cation end product-bovine serum albumin (AGE-BSA). The levels of COX-2
and microsomal prostaglandin E synthase-1 (mPGES-1) were evaluated
using RT-PCR and immunoblot analysis. Prostaglandin E2 (PGE2) levels
were analyzed by ELISA and nitiric oxide (NO) level was measured by
Griess reaction assay.
Results: We found that treatment of OA chondrocytes with AGE-BSA in-
creased COX-2, iNOS, and mPGES-1 mRNA and protein, as well as elevating
production of PGE2. PPAR-γ agonists (CGZ, RGZ, and PGJ2) signiﬁcantly
inhibited AGE-BSA induction of COX-2 and iNOS expression. And CGZ, RGZ,
and PGJ2 inhibited production of PGE2 and NO. But the levels of mRNA and
protein of the mPGES-1were not decreased.
Conclusions: These results suggested PPAR-γ agonists may have protective
effect on AGEs induced OA developement.
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Purpose: To identify factors that modify secretion of extracellular superox-
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ide dismutase (ECSOD) by chondrocytes, affecting the level of antioxidant
protection in joint tissue.
Methods: Human cartilage explant cultures and primary monolayer cul-
tures were used to assess the secretion of ECSOD in basal state and in
response to IL-1 beta, with and without IL-1 receptor antagonist. ECSOD
secretion was measured with an ELISA. Simultaneous determinations of
nitrc oxide production were made using the greiss method.
Results: IL-1beta decreases secretion of EC-SOD from chondrocytes both
in explant and monolayer culture and treatment with both IL-1beta and
IL-1 receptor antagonist together restores ECSOD secretion. As previously
shown we ﬁnd that IL-1 increases nitric oxide while treatment with IL-1
receptor antagonist reduces nitric oxide production.
Figure 1. Mean EC-SOD secretion by human OA cartilage in vitro treated with IL-1beta.
Figure 2. Total nitrate/nitrite measured from OA cartilage treated with and without IL-
1beta.
Conclusions: ECSOD scavenges superoxide and prevents oxidative damage
in the joint. Cartilage tissue generates reactive oxygen species in response
to cytokines and mechanical forces leaving the tissue vulnerable to oxida-
tive damage. Chronic oxidative stress may increase cell senescence, cause
damage to structural matrix proteins and alter cell signaling pathways
leading to osteoarthritis. The ﬁnding that a key inﬂammatory cytokine
(IL-1) decreases the available antioxidant protection in the joint may
explain the progressive joint damage after inﬂammatory pathways are
activated.
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BONE MORPHOGENETIC PROTEIN-2 IS A SPECIFIC CHONDROGENIC
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Purpose: The aim of this study was to investigate if addition of bone
morphogenetic protein (BMP)-2 to human articular chondrocytes (HACs)
could help to maintain their chondrogenic phenotype in long-term culture
conditions necessary for autologous chondrocyte implantation (ACI). We
also evaluated the potential of BMP-2 as a repair factor in combination
with collagen-based biomaterials, to extend the technique to osteoarthritic
lesions.
Methods and Material: In a ﬁrst step, HACs from 19 donors were cultured
independently, according to the procedure used for ACI. Real-time PCR and
Western blotting were used to evaluate the chondrocyte phenotype and gel
retardation assays were performed to analyze DNA binding of transcription
factors under the effect of BMP-2. Next, we evaluated the responsiveness of
HAC to BMP-2 when cultured within collagen sponges. This ﬁrst approach
was undertaken with independent cultures of three donors and the cellular
phenotype was estimated by using real-time PCR.
Results: Exogenous BMP-2 improved the chondrogenic character of HACs
when ampliﬁed over two passages in monolayer. The stimulatory effect
of BMP-2 on type II collagen expression was observed not only at the
mRNA level but also at the protein level, and this is crucial for cartilage
matrix reconstruction. Our preliminary data with HACs ﬁrst ampliﬁed in
monolayer then cultured in collagen sponges in the presence of BMP-2
have revealed that BMP-2 is able to restore COL2A1 gene expression that
was lost during the ampliﬁcation step.
Conclusions: Adding exogenous BMP-2 to HACs expanded in the con-
ditions generally used for ACI or during Matrix-associated ACI is clearly
beneﬁcial to support the chondrocytic phenotype. Importantly, no sign of
hypertrophic maturation or osteogenic induction was detected beside the
chondrogenic stimulatory effect of BMP-2. This study is the ﬁrst to reveal
the beneﬁt of adding exogenous BMP-2 to HACs as a therapeutic agent for
cartilage repair.
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Purpose: Alkaptonuria (AKU) is a rare autosomal recessive condition re-
